Portfolio company
Alithea Biotechnology GmbH
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops immunopeptidomics software and laboratory services for pharmaceutical, biotechnology and academic organisations developing cancer immunotherapies and vaccines.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AilseBio
This biotech company develops artificial intelligence to discover therapy-induced antigens for cancer vaccines and immunotherapies for the healthcare sector.
Antogen
Antogen develops immunopeptidomics tools and diagnostic services for pharmaceutical and biotechnology companies to support therapeutic discovery and clinical trial eligibility testing.
Noetik
This biotechnology company develops precision cancer immunotherapies using machine learning and multimodal human tumour data for pharmaceutical partners and clinical applications.
Deepflare
Deepflare provides an artificial intelligence platform to predict T-cell immunogenicity for biotechnology and pharmaceutical companies developing vaccines and cancer immunotherapies.
Alceus
This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.
Attivare Therapeutics
This biotechnology company develops biomaterial scaffolds and computational platforms to deliver personalised immunotherapies for patients with cancer and infectious diseases.
Infinitopes
This biotechnology company develops precision therapeutic cancer vaccines and antigen discovery platforms for healthcare providers and patients with solid tumours.
Enpicom
This company develops bioinformatics software for immune repertoire sequencing data analysis to assist biotechnology and pharmaceutical firms in antibody discovery and development.
